Reagent and methods for determining cations

Abstract: A reagent, which may be incorporated with a support matrix in a device, for determining an amount of cations present in a sample, the reagent comprising (a) a compound of general formula I wherein k and j, are the same or different, and are each from 1 to about 5; m and n are the same or different, and are each from 0 to about 4; a and e are the same or different, and are each from 0 to about 2; b and d are the same or different, and each from 0 to about 5; each R is independently hydrogen, lower alkyl, lower alkylidene, lower alkenyl,allyl, or aryl; and -Q- is wherein X is CH, N, or COH; and Y includes and (b) one or more interfering cation complexing compound masks.

Description: The present invention concerns a reagent and method for simple and rapid determination of sodium and potassium cations. The qualitative and quantitative determination of cations is of major significance in areas such as chemical and biochemical engineering for process control, in agriculture chemistry for soil research and fertilizer metering and in medicine for diagnostic and therapeutic determination of the potassium-sodium ratio. Present methods for cation determination include flame photometry and atomic absorption spectroscopy, both of which require sophisticated apparatus. Ion-sensitive cation electrodes on an ion-exchange basis generally yield sufficiently differentiated results, but are cumbersome to use. Vogtle, United States patent no. 4,367,072, describes a process for determining ions. It is essentially based on ion-selective complexing between the ion to be determined and a complexing agent and measurement of the extinction change occurring during complexing. The complexing agent is bonded with a chromophore. The selective complexing agent may be an oligoether, oligoester or oligoamide, containing, for example, corand, cryptand or cyclic peptide and/or polyethylene glycol groups or other hetero atom-containing groups. The covalently or heteropolarly bound chromophore is a dye or fluorescent dye or a chromogen whose absorption spectra change through interaction with non-polar ions or lipophilic molecules through charge shifts or disturbances of the mesomeric system. This principle is well known in nature and in the art. Hemin, chlorophyll and metal complex dyes and metal indicators (e.g. xylenol orange and methylthymol blue based on the colorless complexing agent ethylenediaminetetraacetic acid (EDTA)) exhibit, to a greater or lesser extent, this general configuration. A general problem of the above-cited complexing agents is that they usually are capable of reacting only in organic media, whereas the ion being determined is, as a rule, present in an aqueous solution. Although the aqueous solutions of the ions could be transformed in many cases to organic media by concentration, inclusion in organic salts, or solvent extraction, this would not satisfy the requirements of a practical and, if necessary, automated rapid method. Klink, et al., European Patent Publication 85,320, disclose a potassium reagent and a procedure for determining potassium ions. The reagent contains a compound of general formula where n and m = 0 or 1, X = N or COH and R = p-nitrophenylazo, 3-phenylisothiazolyl-5-azo, isothiazolyl-5-azo, thiazolyl-5-azo, 2,4,6-trinitrophenylazo, p-nitrostyryl, p-benzoquinonemonoimino and bis-(p-dimethylaminophenyl) hydroxy-methyl. The potassium ions are determined in a reaction medium consisting of water and at least one water-miscible organic solvent and in the presence of an organic base. Klink et al. provide extinction maxima data of various cations, and state that aside from the extinction maximum for rubidium, all other extinction maxima for the various cations tested (including sodium) are so far removed from potassium's extinction maximum that no interference occurs. However, Klink et al. base their conclusion on data obtained from isolated cation measurements, and do not consider the effect on extinction maxima for these cations in mixed cation solutions. Contrary to the conclusion reached by Klink et al., we have now found that a sodium ion mask greatly enhances determination of potassium ions using chromogenic cryptands described in EP 85,320. More generally, we have found that either sodium of potassium can be selectively assayed rapidly in single-phase aqueous media, by using one or more cation complexing compounds to mask the cation not being assayed. According to the present invention, there is provided a reagent for determining the amount of sodium or potassium cations present in a mixture thereof, the reagent comprising (a) a compound of general formula I wherein k and j are the same or different, and are each from 1 to 5; m and n are the same or different, and are each from 0 to 4, a and e are the same or different, and are each from 0 to 2; b and d are the same or different, and each from 0 to 5; each R is independently hydrogen, lower alkyl, lower alkylidene, lower alkenyl, allyl, or aryl; and -Q- is wherein X is CH, N, or COH; and Y includes and (b) a compound that selectively complexes with potassium or sodium cations (whichever is not being assayed) to mask their presence. The invention also includes a method of selectively determining sodium or potassium cations in a mixture thereof, which comprises combining with said mixture a reagent as defined, and measuring the absorbance of the resulting solution. In one preferred embodiment of the method, an aqueous reagent of the invention is used and, before contact with the mixture, the reagent is added to a device comprising a dimensionally stable, uniformly porous, diffusely reflective single or multi-layer formed of a polymeric matrix, and the water is evaporated from the reagent mixture; the device is then contacted with the mixture; and the reflectance of the device is measured. Suitable cation complexing compound masks are non-chromogenic and include spherands, hemispherands, cryptahemispherands, cryptands, and corands. Spherands, hemispherands, and cryptahemispherands which are structurally oriented so as to complement a particular cation are preferred in the present invention. Such masks may be referred to as "pre-organized". Cram et al (J. Am. Chem. Soc. 1986, 108, 2998-3005) disclose cryptahemispherands which have a high specificity for sodium or potassium ions. Cryptands and corands which have cavity sizes matching particular cation diameters are also preferred in the present invention. Suitable compounds for masking sodium include, but are not limited to: where each of R₁,R₂,R₃,R₄,R₅,R₆,R₇,R₈,R₉,R₁₀,R₁₁, and R₁₂, is independently hydrogen, lower alkyl, lower aryl, lower alkenyl, allyl or lower alkylidene. Kryptofix® 2.1.1:4,7,13,18-tetraoxa-1,10-diazabicyclo(8,5,5)-eicosane is surprisingly effective as a sodium mask. Sodium ion complexing is beneficial in determining potassium in a sample such as blood serum which contains a high concentration of sodium. The reagent may further comprise one or more water-miscible organic solvents and a buffer. The reagent may comprise a surfactant. Suitable compounds for masking potassium include, but are not limited to: where R₁ is hydrogen, lower alkyl, lower aryl, lower alkenyl, allyl or lower alkylidene. In the accompanying drawings, the various Figures are as follows: FIGURE 1: Reaction pathway for synthesizing chromogenic cryptand 3.2.2. FIGURE 2: Absorbance data for potassium assay with and without Kryptofix® 2.1.1 mask. FIGURE 3: Absorbance data for sodium assay with Kryptofix® 2.2.1:4,7,13,16,21-pentaoxa-1,10-diazabicyclo (8,8,5)-tricosane mask. FIGURE 4: Correlation plot of sodium assay with Kryptofix® 2.2.1 mask and state-of-the-art method. FIGURE 5: Dry chemistry analytical element sodium response to chromogenic cryptand 2.2.2 with Kryptofix® 2.2.1 mask. FIGURE 6: Dry chemistry analytical element sodium response to chromogenic cryptand 2.2.2. without Kryptofix® 2.2.1 mask. In accordance with the invention, quantitative determination of sodium and potassium in blood serum and other biological fluids can be made in a homogeneous single phase solvent system that requires no sample pretreatment. The reagents of this invention may be utilized for making sodium and potassium determinations on automated clinical chemistry analyzers such as the Technicon CHEM-1 R clinical chemistry analyzer, the Technicon RA-1000 R clinical chemistry analyzer and the Technicon SMAC R clinical chemistry analyzer. Additionally, the reagents of this invention may be utilized in compositions for making sodium and potassium determinations on industrial or other non-clinical chemistry automated analyzers such as the Technicon TRAACS 800 TM analyzer. Moreover, the reagents may be utilized in compositions for making cation determinations by manual methods or standard UV/vis spectrophotometers. The sample fluids on which the cation determinations can be performed using the reagents of this invention include biological, physiological, industrial, environmental and other types of liquids. Of particular interest are biological fluids such as serum, plasma, urine, cerebrospinal fluids, saliva, milk, broth and other culture media and supernatant, as well as fractions of any of them. Other sources of sample fluid which are tested by conventional methods are also contemplated and can have ionic determinations performed on them in accordance with this invention. The solvent system consists of water and water miscible organic solvent in proportions to obtain maximum sensitivity but to avoid sample pretreatment, such as protein precipitation, extraction or phase separation. Cyclic ethers, glycol ethers, amides, aliphatic alcohols with, for example, three to eight carbon atoms and/or sulfoxides possess excellent photometric and visually evaluable color gradations and are suitable water-miscible organic solvents useful in the present invention. Dioxane and tetrahydrofuran are particularly suitable as cyclic ethers, while ethylene glycol monoalkyl ethers, particularly methyl, ethyl, propyl and butyl cellosolve, are suitable as glycol ethers, and formamide, dimethylformamide (DMF), pyrrolidone and N-alkylpyrrolidones, e.g, N-methylpyrrolidone (NMP), are suitable as amides. Aliphatic alcohols such as methanol and ethanol are also suitable, but better results are obtained in alcohols with three to eight carbon atoms such as isopropanol, n-propanol, butanols, amyl alcohols, hexanols, heptanols and octanols. Dimethyl sulfoxide is also a suitable solvent. The water-dioxane solvent system has proved particularly advantageous. It has been found that a large number of water-miscible organic solvents, such as, for example, acetone, methyl ethyl ketone and glacial acetic acid are unsuitable as reaction media. The preferred solvent system of the present invention differs from Klink, et al., which teaches suitable reagent solvent systems as including a water-miscible organic solvent in amounts achieving a water to organic solvent ratio of about 1:4 to 1:6. In the present invention, solvent systems having a water to organic solvent ratio of about 1:0.5 to 1:2, are preferably used, and the systems preferably include a surfactant and higher pH. The solvent system of the present invention obviates the need for removal of protein from a serum sample. Other components may also be included in the reagents of this invention, such as buffers and stabilizers. Additional ion masks may be employed to remove the effect of interfering ionic species. Because of the importance of maintaining pH at a specific level in making accurate cation determinations, buffer may be included in the reagents of this invention for the purpose of controlling the pH. Suitable buffers for maintaining the pH include cyclohexylaminopropanesulfonic acid (CAPS), cyclohexylaminoethanesulfonic acid (CHES), triethanolamine, diethanolamine, ethanolamine, 2-naphthalene sulfonic acid, and salicylic acid. Preferably, in making a cation determination, the pH of the composition is maintained at about 9-12. The reagents of this invention may also include a surfactant in order to aid in protein solubilization. Surfactants are also used in many automated analyzers for hydraulic reasons. Suitable surfactants for use in the reagents of this invention include sorbitan monooleate (commercially available as Tween-80 R from ICI Americas Co. of Wilmington, DE) and polyoxyethylene lauryl ether (commercially available as Brij-35 R from ICI Americas of Wilmington, DE). Reagents of the invention are mixed with a sample containing the mixture of sodium and potassium ions to be tested. After mixing of reagent and sample, absorbance of the resulting solution is measured to determine concentration of the cation of interest. In one embodiment of the method of the invention, the reagent is added to a device comprising a dimensionally stable, uniformly porous, diffusely reflective single or multi-layer carrier matrix, and the water is evaporated from the reagent; the device is then contacted with the mixture; and the reflectance of the device is measured. The carrier matrix comprises a porous or wettable material. In a single layer format, the carrier matrix can be formed from materials such as paper, cardboard, porous polymers, polymer fiber and natural felts, and other suitable materials. Preferred as carrier matrix materials are filter paper, and porous high density polyethylene. In a multilayer analytical element format, the buffer can be stored in an upper layer and the cryptand in a lower layer in a superposed laminar fashion. The matrices for these layers can be formed from materials such as gelatin, water soluble or water swellable polymers, and other suitable materials. In addition to those two layers, a spreading layer, a reflecting layer and a support material can be incorporated to form an integral analytical element. In the following embodiment of the invention, the preferred sample is blood serum or plasma, the preferred carrier matrix is a device that is a dimensionally stable, uniformly porous, diffusely reflective single layer formed of a polymeric non-fibrous matrix, and the preferred method comprises the following steps: (a) preparing a reagent mixture consisting essentially of one or more water-soluble polymeric binders, a surfactant, a chromogenic cryptand according to formula I for complexing sodium or potassium, a compound for complexing potassium or sodium to mask it, water and a buffer; (b) adding the reagent to the device; (c) evaporating the water of the reagent; (d) adding the sample to the device; and (e) measuring reflectance of the device. Preferred reagents comprise one or more water soluble polymeric binders selected from the group including polyvinyl alcohol, polyvinyl pyrrolidone, polyacrylic acid, methyl cellulose, hydroxymethylcellulose and gelatin. Preferred reagents further comprise one or more organic buffers. Examples of suitable organic buffers include triethanolamine, diethanolamine, ethanolamine, 2-naphthalene sulfonic acid, CAPS and CHES. Suitable buffers maintain a pH in the range of 9 to 12. The matrix may be constructed in one of several ways. One suitable way involves sintering fine particulates of a high-density polyethylene, ultra-high molecular weight polyethylene, polypropylene, polyvinylidene fluoride, polytetrafluoroethylene, nylon, polyvinylchloride polyesters, polysulfones and blends thereof. The matrix may be coated with a hydrophilic surfactant selected from the group including polyoxyethyleneoctyl phenols, polyoxyethylenenonyl phenols, and polyoxyethylenelauryl ethers. By incorporating a suitable carrier matrix with the reagent, cation determination can be done using such a device. Such a device lends itself to dry storage when not in use, thus enabling long shelf-life, and can be pressed into service immediately simply by contacting it with a small portion of the test sample, be it blood, serum, urine or other aqueous solution to be assayed. It can take on such formats as a dip-and-read strip for urine or a test slide for use with an automatic blood analyzer, or can form a multilayer structure such as is described in United States Patent Nos. 3,992,158 and 4,292,272. It is desirable that the carrier matrix comprise a porous or wettable material. Thus, in a single layer format the carrier matrix can be formed from materials such as paper, cardboard, porous polymers, polymer fiber and natural felts, and other suitable materials. Especially preferred as carrier matrix materials are filter paper, and porous high density polyethylene. In a multilayer analytical element format, the buffer can be stored in an upper layer and the chromogenic cryptand in a lower layer in a superposed laminar fashion. The matrices for these layers can be formed from materials such as gelatin, water soluble or water swellable polymers, and other suitable materials. In addition to these two layers, a spreading layer, a reflecting layer and a support material can be incorporated to form an integral analytical element. The device is prepared by incorporating the carrier matrix with the test composition and, if desired, providing dried matrix with a support. Thus the composition is applied to the matrix by innoculating the surface of the matrix or by dipping it into a solution of the composition. The thus-impregnated matrix can then be dried at room temperature or at elevated temperatures provided the temperature is not so high as to deleteriously affect the composition. The dried, impregnated carrier matrix can then be mounted, if desired, on a suitable support such as a circumferential frame which leaves the matrix exposed to the middle; or the matrix can be mounted at one end of a plastic strip, the other end serving as a convenient handle. In one embodiment of the invention, the test sample containing sodium is contacted with the surface of the test device and the detectable response is measured at 650 nm or other appropriate wavelength on a reflectometer. Experiments using varied known sodium concentrations yield a dose/response curve enabling clear correlation between changes in percent reflectance and sodium concentration in the millimolar range. The following examples illustrate but are not intended to limit the scope of the present invention. EXAMPLES Example 1 A preferred chromogenic 3.2.2 cryptand was synthesized by the reaction pathway shown in Figure 1, and is shown as compound 7. Bis(1,3-methylacetoxy)-2-methoxybenzene 2 . To a stirred mixture of anhydrous K₂CO₃ (30g) and methyl bromoacetate (30.5g, 0.20 mol) in 400 ml of acetone was added dropwise under nitrogen a solution of 2-methoxy-resorcinol 1 in 100 ml of acetone. The mixture was refluxed for 30h. Filtration of the inorganic material and evaporation of the solvent gave a residue which was column chromatographed on silica gel with methylene chloride - methanol (50:1) to afford 19.3g (95%) of 2 as a colorless, viscous liquid which solidified during storage in the form of white crystals; M.P. 70-72° C. Calcd. for C₁₃H₁₆O₇ (percent): C, 54.33; H, 5.67 Found: (percent): C, 54.82; H, 5.55. 1,3-Di(oxyacetic acid)-2-methoxybenzene 3 . Dimethylester 2 (4.00g, 14 mmol) was suspended in 250 ml of water containing Amberlyst IR-120(H⁻)(0.5g). The mixture was refluxed for 8h. The resin was filtered and the water solution concentrated. A white crystalline material was separated and dried to give 3.33g (93%) of diacid 3 ; M.P. 148-150° C (lit.¹ mp 150-152° C). Diacid Chloride 4 . Diacid 3 (2.50g. 9.8 mmol) was suspended in 15 ml of chloroform and the mixture was heated to reflux. Thionyl chloride (3 ml) was added dropwise to the refluxing suspension and it was refluxed overnight to give an almost clear solution. The reaction mixture was cooled, filtered, and evaporated in vacuo to afford 2.74g (96%) of a pale yellow solid with mp 61.5-63.5°C which was used subsequently without purification. Methoxybenzo Cryptand Diamide 5 . Solutions of diacid chloride 4 (1.99g, 6.81 mmol) in 100 ml of toluene and Kryptofix® 3.2 (2.08g, 6.81 mmol) and triethylamine (1.77g) in 100 ml of toluene were simultaneously added to 250 ml of rapidly-stirred toluene at 0°C under nitrogen with two syringe pumps during 4h. After completion of the addition, the reaction solution was stirred at room temperature overnight. The solid material was filtered and the filtrate was evaporated in vacuo. The residue was chromatographed on silica gel with chloroform-ethanol (20:1) as eluent to give 2.38g (54%) of 5 as a colorless, hygroscopic oil. Calcd. for C₂₅H₃₈N₂O₁₀ (percent): C,57.02; H,7.27. Found (percent): C, 56.80: H, 7.42. Cryptand Phenol 6 . The cryptand diamide 5 (1.25g, 2.4 mmol) was added to a suspension of lithium aluminum hydride (0.76g, 20.0 mmol) in tetrahydrofuran (80 ml) and the mixture was refluxed for 20h. After cooling, 4.0 ml of 5% NaOH was added. The inorganic material was filtered and washed several times with hot tetrahydrofuran. The combined filtrate and washings were evaporated in vacuo and the residue was chromatographed on alumina to give 0.99g (85%) of 6 as a colorless, hygroscopic oil. Calcd. for C₂₄H₄₀N₂O₈H₂O (percent): C,57.35; H, 8.42. Found (percent):C, 57.70; H, 8.32. Chromogenic Cryptand 7 To cryptand phenol 6 (0.85g, 1.75 mmol) was added 32% NaOH until the aqueous solution was basic. The clear, brown oil was separated and dried in vacuo. Acetic acid (20 ml) was added to the residue to give a clear solution which was cooled to O°C. A solution of p -nitrobenzenediazonium tetrafluoroborate (0.47g, 2.0 mmol) in water (25 ml) was added dropwise with vigorous stirring. The mixture was stirred overnight at room temperature and then evaporated to dryness. Column chromatography on alumina with chloroform-ethanol (20:1) gave 0.75g (70%) of 7 as a dark-red oil. Calcd. for C₃₀H₄₃N₅O₉H₂O (percent): C, 56.68; H, 7.13. Found (percent) C, 56.45; H, 7.18. Example 2 An experiment was performed to ascertain the response of the chromogenic agent of Klink et al., European Patent application number 83,320 to potassium in the presence or sodium as would be encountered in human serum samples. Preparation of reagent was as described by Klink, et al. and when combined with aqueous sample containing zero to ten parts per million (ppm) potassium (1.5 mM) and zero or 6mM sodium (140ppm) gave a solution with the final concentration of individual components: 1,4-dioxane 80% morpholine 2.4% DMSO 1.6% chromogenic cryptand 2.2.2 (Klink et al.) 0.0008% aqueous sample 16% When no sodium is present in sample there is a significant response to potassium as described by Klink et al. However, in the presence of even low concentrations of sodium as studied here, the response to potassium is negligible. It is clear that such a chromogenic reagent, by itself, has insufficient selectivity to determine the concentration of potassium ion in human serum or other samples where there exists a large excess of interfering sodium ions. In an experiment under similar conditions to those described by Klink, et al., the response of chromogenic cryptand to potassium was studied. When sodium ion was present in the same sample, loss of chromogenic cryptand response to potassium was observed. Reagent Formulation A. Dissolve approximately 4.16 mg Klink et al, cryptand 2.2.2 into 5 ml 1,4-dioxane. B. Add 2.4 ml morpholine, 1.6 ml dimethylsulfoxide and 16 ml distilled water to 80 ml 1,4-dioxane and mix. C. Pipet 0.5 ml of solution A into 19.5 ml solution B. This solution will be used for the assay of potassium ions. Standards Prepare 0 - 10 mM NaCl in a 10 mM KCl background. Assay Add 0.15 ml standards to 2.1 ml of solution C and read the change in absorbance at 566 nm in a spectrophotometer. Results Response to potassium in absence or presence of sodium ion is shown below. The results clearly indicate that under mixed ion conditions, the response to potassium is drastically reduced in the presence of sodium. Example 3 A potassium assay was performed in serum using compositions of this invention and comprising chromogenic cryptand 2.2.2. of Klink et al. (shown as formula II) below: Reagent Formulations Formulation (a) 4.12 mg of the chromogenic compound II was dissolved into 50ml dioxane to form a chromogenic compound - dioxane solution. 8.85g cyclohexylaminopropanesulfonic acid was dissolved into 30 ml H₂O 0.186g ethylenediaminetetraacetic acid and 10 ml 1M tetramethylammonium hydroxide were added, and stirring was continued until all solids were dissolved. After all solids were dissolved, 5g Tween-80® (ICI) were added. pH was adjusted to 12.0 using 1M tetramethylammonium hydroxide and volume was brought to 50 ml with distilled water. Finally, the chromogenic compound-dioxane solution was added, and stirring was continued until the reagent was well-mixed. Formulation (b) A second formulation was prepared as described above except that 0.432g Kryptofix® 2.1.1 (E. Merck) (a non-chromogenic sodium mask) was added. Assay 0.98 ml reagent was mixed with 0.02 ml sample. Absorbance at 530 nm on a Beckman DU8 Spectrophotometer was measured. A series of standard potassium samples with concentration ranging between 0 and 10mM was prepared in a 140 mM sodium chloride solution and assayed by using formulations (a) and (b). Results The data for the assay of these samples with formulations (a) and (b) is represented in figure 2. The results clearly showed that there is no response to increasing potassium concentration in formulation (a) that contains no sodium mask Kryptofix® 2.1.1, whereas the converse is true for the assay using formulation (b) containing Kryptofix® 2.1.1. Example 4 An experiment was conducted to compare a preferred composition of the present invention with a state-of-the-art method for measuring potassium in serum. A series of random serum samples containing a broad range of potassium concentration was obtained. The samples were assayed on a RA-1000® analyzer (Technicon Instruments Corporation) using the reagent formulation listed below: 1.69 x 10⁻⁴M chromogenic cryptand 3.2.2 (compound 7 of Fig. 1) 3.0 x 10⁻²M Kryptofix® 2.1.1 4.0 x 10⁻³M EDTA (divalent ion mask) 60% (v/v) Ethoxyethoxyethanol (water miscible organic solvent) pH 11 CAPS 0.12M (buffer) 2.5% (w/v) Tween-80® (surfactant) The parameters on the RA-1000® instrument were as follows: sensitivity 12.0 mA/mM method end point temperature 37°c wavelength 540 nm sample volume 4 µl reagent volume 395 µl delay 5 min. pH 11.5 dilution ratio 1:100 Result The absorbance output from the RA-1000® instrument for each sample was recorded and converted to potassium concentrations. The same set of serum samples was also assayed by RA-1000 ISE® module for potassium concentrations. Correlation data on RA-1000® analyzer Reference method RA-1000 ISE® slope 1.10 intercept -0.26 correlation coefficient 0.9704 number of serum samples 41 Linear range, mM 0-14 Precision, CV 2.2% The data show good agreement between the method of the present invention and the state-of-the-art ISE methodology. Example 5 A sodium assay was performed in serum using compositions of this invention comprising a controlled amount of non-chromogenic sodium mask Kryptofix® 2.2.1 and chromogenic cryptand 2.2.2. of Klink et al. (structure II) Reagent Formulation 6.63g cyclohexylaminopropanesulfonic acid was dissolved into 80 ml H₂O. 0.186g ethylenediaminetetraacetic acid and 10 ml 1M tetramethylammonium hydroxide were added. Stirring continued until all solids were dissolved and then 80 mg Kryptofix® 2.2.1 and 0.2g Triton® x-100 were added. pH was adjusted to 11.15 with 1M tetramethylammonium hydroxide. 2.5 ml solution of the chromogenic cryptand 2.2.2 (2.1 mg in 2.5 ml dioxane) was then added and volume was increased to 100 ml with distilled water. Assay 0.98 ml reagent was mixed with 0.02 ml sample, and absorbance at 600 nm with a Beckman DU8 Spectrophotometer was measured. A series of standard samples with known sodium concentration was assayed. Result The plot of sodium concentration against absorbance measured at 600 nm is shown in Fig. 3. Example 6 An experiment was conducted to compare a preferred composition of the present invention with a state-of-the-art method for measuring sodium in serum. A series of random serum samples containing a broad range of sodium concentration was obtained. The samples were assayed on RA-1000® instrument using the reagent formulation of Example 5. The parameters on the RA-1000® instrument were set as follows: Sample Volume 5.0 µl Reagent Volume 395 µl Optical Filter 600 nm Temperature 37°C Delay 5 min. Assay type end point The absorbance output from the RA-1000® instrument for each sample was recorded and converted to sodium concentrations using the plot of a calibration curve. The same set of serum samples were also assayed by RA-1000 1SE® module for sodium concentrations. The assay results of the present invention were plotted against the assay results of the state-of-the-art RA-1000 ISE® module. The plot is depicted in figure 4 and clearly shows a good correlation between the present invention and the state-of-the-art methodology. Example 7 An experiment was conducted to compare a second preferred composition of the present invention with a state-of-the-art method for measuring sodium in serum. A series of random serum samples containing a broad range of potassium concentration was obtained. The samples were assayed on RA-1000® instrument (Technicon Instruments Corporation) using the reagent formulation listed below: 1.35 x 10⁻⁴M Chromogenic cryptand 3.2.2 (compound 7 of Fig. 1) 2.0 x 10⁻³M Cryptand 3.2.2. (potassium mask) 5.0 x 10⁻³M EDTA 50% (v/v) Ethoxyethoxyethanol (water miscible organic solvent) pH 11.2 CAPS 0.15M 2.5% (w/v) Tween-80® Cryptand 3.2.2 is represented by The parameters on the RA-1000® instrument were as follows: sensitivity 1.7 mA/mM method end point temperature 37°C wavelength 600 nm sample volume 4µl reagent volume 395µl delay 5 min. pH 11.2 dilution ratio 1:100 Result The absorbance output from the RA-1000® instrument for each sample was recorded and converted to sodium concentrations. The same set of serum samples was also assayed by RA-1000 ISE® module for sodium concentrations. Correlation data on RA-1000® instrument Reference method RA-1000 ISE® slope 1.13 intercept -12.47 correlation coefficient 0.9505 number of serum samples 80 Linear range mM 80-200 Precision, CV 2.1% The data show good correlation between the method of the present invention and the state-of-the-art methodology. Example 8 The following example demonstrates the use of chromogenic cryptand 2.2.2 of Klink et al. in conjunction with Kryptofix® 2.2.1 to mask a fixed amount of sodium ions in an analytical sample allowing measurement without dilution. Dry reagent analytical element was prepared as follows. To each 1/2 inch diameter porous disk (HDPE, 35 um, 1/32-inch thick), 35 microliter of a reagent mixture containing 1.0 ml distilled water, 1 mg chromogenic cryptand 2.2.2, 70 mg cryptand 2.2.1, 10 mg polyvinyl alcohol, 10 mg polyvinyl pyrrolidone, and 0.1 gm Triton®x-100 were deposited, and the disks were allowed to dry at room temperature for five hours before storing in a desiccator for two hours. The disks were tested with 25 microliter analytical sample containing 0.2 M CAPS buffer, pH 11.0. The diffuse reflective signals after two minutes incubation at room temperature were measured at 650 nm on a modified Infra-Alyzer (Technicon Instruments Corporation). The reflectance, R measurements were transformed to K/S functions where The plot of K/S versus sodium concentration as shown in Figure 5 demonstrates an inverse relationship from 80 mM to 180 mM sodium. In the absence of Kryptofix® 2.2.1, the dynamic range was narrow, from zero to 20 mM sodium as shown in Figure 6.

Claims: A reagent for determining the amount of sodium or potassium cations present in a mixture thereof, the reagent comprising (a) a compound of general formula I wherein k and j, are the same or different, and are each from 1 to 5; m and n are the same or different, and are each from 0 to 4; a and e are the same or different, and are each from 0 to 2; b and d are the same or different, and each from 0 to 5; each R is independently hydrogen, lower alkyl, lower alkylidene, lower alkenyl, allyl, or aryl; and -Q- is wherein X is CH, N, or COH; and Y includes and (b) a compound that selectively complexes with potassium or sodium cations (whichever is not being assayed) to mask their presence. A reagent according to claim 1, for the assay of potassium, wherein the sodium mask is a spherand, hemispherand or cryptahemispherand, structurally oriented so as to complement the ionic diameter of sodium, or a cryptand or corand having a cavity size matching the size of a sodium ion. A reagent according to claim 1 for the assay of sodium, wherein the potassium mask is a spherand, hemispherand, or cryptahemispherand, structurally oriented so as to complement the ionic diameter of potassium, or a cryptand or corand having a cavity size matching the size of a potassium ion. A reagent according to claim 1,2 or 3, further comprising water and a water-miscible organic solvent. A reagent according to claim 4, further comprising a buffer for maintaining the reagent pH at between 9 and 12. A reagent according to claim 4 or 5, further comprising a surfactant, and wherein the water to organic solvent ratio is between 1:0.5 and 1:2. A reagent according to claim 6, wherein the surfactant is a polyoxyethylenelauryl ether or sorbitan monooleate. A method of selectively determining sodium or potassium cations in a mixture thereof, which comprises combining with said mixture a reagent as defined in any of claims 4 to 7, and measuring the absorbance of the resulting solution. A method of selectively determining sodium or potassium cations in a mixture thereof, wherein a reagent as claimed in claim 4,5,6 or 7, is added to a device comprising a dimensionally stable, uniformly porous, diffusely reflective single or multi-layer carrier matrix, and the water is evaporated from the reagent; the device is then contacted with the mixture; and the reflectance of the device is measured. A method according to claim 9, wherein the matrix comprises one or more of high-density polyethylene, ultra-high molecular weight polyethylene, polypropylene, polyvinylidene fluoride, polytetrafluoroethylene, nylon, polyvinylchloride, polyesters and polysulfones. A method according to claim 9 or 10, wherein the matrix is a hydrophobic porous polymer sheet. A method according to claim 9,10 or 11, wherein the matrix is coated with a hydrophilic surfactant. A method according to claim 9,10,11 or 12, wherein the surfactant is a polyoxyethylene octyl phenol, polyoxyethylene nonyl phenol or a polyoxyethylene lauryl ether.

Inventors: CHAPOTEAU EDDY, CZECH BRONISLAW P, GEBAUER CARL R, KUMAR ANAND, LEONG KOON-WAH, CHAPOTEAU, EDDY, CZECH, BRONISLAW P., GEBAUER, CARL R., KUMAR, ANAND, LEONG, KOON-WAH
Applicants: MILES INC, MILES INC.(AN INDIANA CORP.)
Application year: 1988
Main classification: G01N33
IPC codes: C07D498, G01N33, G01N31